ArticleJournal of ophthalmology2026
Effect of Shallow Anterior Chamber on Postoperative Refractive Status in Patients of Age-Related Cataract.
Article in Journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effect of Shallow Anterior Chamber on Postoperative Refractive Status in Patients of Age-Related Cataract.Journal of ophthalmology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To assess how shallow anterior chamber depth (ACD) affects refractive error (RE) after cataract surgery and compare modern intraocular lens (IOL) formulas in patients with normal axial length. Methods: This prospective study enrolled patients undergoing phacoemulsification with IOL implantation at Jinan No. 2 People's Hospital (June 2023-December 2024). Patients were divided based on ACD into two groups. Biometrics were measured using IOLMaster 700, and IOL power was calculated with the Barrett Universal II (BUII) formula. Patients were reassessed at 1 and 3 months postoperatively. We analyzed correlations between RE and biometrics and compared BUII, Kane, EVO 2.0, and Hill-RBF 3.0 formulas. Results: A total of 103 patients were divided into two groups: shallow (ACD < 2.5 mm, Conclusion: Shallow ACD independently increases hyperopic shift risk. While all formulas are effective in normal eyes, BUII is superior in shallow chambers. Preoperative ACD and lens thickness assessment is crucial, and slight IOL power adjustment may optimize outcomes in shallow ACD cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.